Form 4: William R. Frist Receives HCA Healthcare Equity Award
Statement of Changes in Beneficial Ownership
Director William R. Frist acquired 809 restricted share units as part of his annual director compensation package.
Summary
- Director William R. Frist was granted 809 restricted share units (RSUs) by HCA Healthcare, Inc. on April 28, 2026.
- The grant consists of 509 RSUs for the annual director equity award and 300 RSUs in lieu of an annual cash retainer.
- The RSUs vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.
- Vested shares will be delivered to the director upon his departure from the Board of Directors.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
- Director opted to receive equity in lieu of cash, signaling confidence in the company's future performance.
Negatives
- None identified; this is a standard director compensation disclosure.
Risks
- None identified; this is a standard director compensation disclosure.
Future Outlook
The RSUs are scheduled to vest in 2027, with delivery of shares deferred until the director leaves the board.
Industry Context
StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board incentives with shareholder interests, particularly in the healthcare services sector.
Comparison to Industry Standards
- The use of RSUs for director compensation is consistent with standard practices among S&P 500 healthcare companies.
- Deferring share delivery until board departure is a common governance mechanism to ensure long-term commitment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Director elected to receive 300 RSUs in lieu of an annual cash retainer. | 04/28/2026 | Neutral; aligns director compensation with equity performance. |
Related Party Transactions
- The filing discloses significant indirect holdings by the reporting person through Frisco Holding II and Hercules Holding II, which are associated with the HCA founder's family.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard compensation disclosure.
Next Steps
- Vesting of the 809 RSUs at the 2027 annual shareholders' meeting or the first anniversary of the grant.
Key Dates
| Date | Description |
|---|---|
| 04/28/2026 | Date of the equity grant transaction. |
| 04/30/2026 | Date the Form 4 was filed with the SEC. |
Keywords
HCA Healthcare, Form 4, Insider Trading, Director Compensation, Equity Award, William R. Frist
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.